INTRODUCTION
Thyroid dysfunction and thyroid autoimmunity are common among women of reproductive age. 1 Epidemiological studies in Indian population has shown a significant prevalence of clinical and subclinical hypothyroidism in women. 2 The prevalence of thyroid dysfunction during pregnancy is estimated to be 2-5%. 2 Thyroid autoantibodies are found in 10-20% of women of reproductive age. 7 Majority of the women who test positive for thyroid autoantibodies are euthyroid. Prevalence of hypothyroidism in India ranges from 6.47%-14.3%. 4 
Physiological changes of Thyroid during Pregnancy
Normal pregnancy is associated with significant changes in maternal thyroid physiology. Beta-hCG has a thyrotrophic activity and shares 85% homology with beta subunit of TSH. As a result of this TSH level decreases in early pregnancy in comparison to non-pregnant women. 5, 6 Total T 3 and T 4 levels increase by 30-40% owing to the increase in thyroid binding globulin levels. Changes in the levels of free T 3 and T 4 during pregnancy are controversial.
Serum TSH concentration is the most reliable and inexpensive test for assessing thyroid function in pregnancy. Diagnosing thyroid dysfunction during pregnancy may be complicated due to the impact of Department of Obstetrics and Gynaecology, Rajarajeshwari Medical College and Hospital, Bangalore, Karnataka, India pregnancy on thyroid homeostasis that can make interpretation of thyroid function difficult. Use of trimester specific and assay specific TSH normal range is recommended. In the first trimester of pregnancy normal TSH is ≤2.5 mIU/l and in second and third trimester ≤3 mIU /l. [6] [7] [8] Autoimmune thyroid dysfunction is the common cause of both hypothyroidism and hyperthyroidism. Graves' disease accounts for 85% of all cases of hyperthyroidism, whereas Hashimoto's thyroiditis is the common cause of hypothyroidism.
The presence of thyroid autoantibodies might be a marker of underlying subtle alteration in thyroid reserve. A reduction in the functional reserve of the thyroid gland associated with reduced adaptation to the physiological changes of pregnancy could contribute to minor changes in circulating thyroid hormone concentrations. The increase in thyroid stimulating hormone concentrations in pregnant women with thyroid autoantibodies supports this hypothesis. 16 There is evidence that there is an alteration in cytokine expression by peripheral T lymphocytes in women positive for thyroid antibodies outside of pregnancy. Pregnancy is an inflammatory process involving a shift in the regulation of cytokine networks within the local placental-decidual environment. Dysregulation of local inflammatory processes can be associated with miscarriage and premature delivery. The presence of thyroid autoantibodies reflects a generalised activation of the immune system and specifically an activity of the immune system at the fetal-maternal interface. Thyroid hormones can directly influence angiogenic growth factor and cytokine production as well as trophoblast proliferation, survival, and invasion. 7, 8, 17 This probably explains the role of thyroid autoimmunity in causing adverse effects like miscarriage, preterm delivery, preeclampsia, abruption placenta, anaemia, low birth weight babies, postpartum haemorrhage. 7, 8 Objectives  To study the prevalence of thyroid autoimmunity in pregnant women  To study the effect of thyroid autoimmunity on maternal and fetal outcome
METHODS
It was an observational clinical study conducted at RRMCH, over a period of six months. Study group included pregnant women attending antenatal clinic at RRMCH from May-13 to Oct-13.They were subjected to thyroid screening using chemiluminescent assay. Women with abnormal thyroid profile were included in the study group. They were screened for presence of anti-thyroid antibodies. Pregnancy outcomes of women with anti TPO antibodies positive were compared with anti TPO antibody negative women. Women with other autoimmune disorders, hypothyroidism on treatment were excluded from the study.
TSH was done by using ultra-sensitive sandwich chemiluminescent immunoassay. T 3 and T 4 were done by competitive chemiluminescent immunoassay. Anti TPO antibodies was done using fully automated chemiluminescent immunoassay. Trimester specific TSH values were taken into consideration. First trimester 0.05-2.5 µIU, second and third trimester 0.18-3 µIU were considered normal. TSH values more than 2.5 µIU in first trimester and more than 3 mU in second and third trimester with normal free T 3 and T 4 were diagnosed as subclinical hypothyroidism. TSH more than 4.5 µIU with low free T3 and T4 were diagnosed overt hypothyroidism. TSH less than 0.01 µIU were diagnosed hyperthyroidism.
The study was approved by ethical committee of RRMCH.
Statistical methods
Descriptive and inferential statistical analysis was carried out in the present study. Results on continuous measurements were represented on Mean ± SD (MinMax) and results on categorical measurements were presented in Number (%). Significance was assessed at 5 % level of significance. Chi-square/Fisher Exact test were used to find the significance of study parameters on categorical scale between two or more groups. 
RESULTS
A total of thousand pregnant women were included in the study. One hundred and twenty six women were detected to have high TSH values. Twenty six women with hypothyroidism were detected anti TPO antibody positive, one woman had hyperthyroidism. Prevalence of hypothyroidism was 7.5% and autoimmunity was 12.8% in this study. Table 2 shows the demographic details of the mothers with high TSH and thyroid autoimmunity. Mean maternal age was similar in both study groups, around 25-26 years. Most of the women were antenatal booked cases (88%) in both groups. Most women included in the study had BMI of 24.9 in both groups. Most women in Anti TPO positive group were multigravida (60%). Most of them had bad obstetric history. Table 4 shows association of thyroid autoimmunity and adverse maternal outcome. 46.2% women with anti TPO positive had pre-eclampsia, p value <0.001.7.7% women with anti TPO positive had GDM, P value 0.6.3.8% women with anti TPO positive had anaemia, P value 1.0. Table 5 shows association of thyroid autoimmunity with adverse fetal outcomes. 7.7% had IUD; P value 0.042. 15.4% had IUGR, P value 0.033. n=3 had SGA, P value 0.71.
DISCUSSION
In this study prevalence of hypothyroidism and thyroid autoimmunity were obtained and its relation to adverse outcomes such as PE, GDM, IUGR, SGA were studied.
Prevalence of hypothyroidism was 7.5% in this study. 18 Prevalence of subclinical hypothyroidism in women with thyroid autoimmunity was 12.6% in our study. Prevalence of thyroid autoimmunity and subclinical hypothyroidism was 18.5% in studies of Dhanwal et al. 3 We found increased risk of PE in women with hypothyroidism and thyroid autoimmunity. 46.2% of women with anti TPO antibodies positive had PE in comparison to 10% with anti TPO Negative P value <0.001. Studies of Mecacci et al. and Karkosta et al. showed 33.3% and 4.7% of women with thyroid autoimmunity had PE respectively. Indian studies showed similar results. 8, 13, 14 Studies of Alwin Azi showed no significance of thyroid autoimmunity and hypothyroidism in prevalence of PE. 10, 11 In our study 7% of women with anti TPO antibody negative had preterm delivery. Studies of Wang et al. and Alex Stangaro Green showed similar results. 9 There are many studies showing relation between autoimmunity and preterm labor. Pregnancy represents an inflammatory process with a shift in the regulation of cytokine networks within the local placental-decidual environment, a deregulation of the local inflammatory processes can be associated with miscarriage and premature delivery. 7, 8 In our study 7.7% of women with thyroid autoimmunity had GDM in comparison to 4% without autoimmunity, p value of 0.603 in this study. 
CONCLUSION
High prevalence of hypothyroidism and Thyroid autoimmunity during pregnancy makes it an important health problem. Most of the thyroid dysfunctions manifest during pregnancy and they go undiagnosed as most symptoms may mimic symptoms related to pregnancy. Early screening of thyroid function and timely initiation of treatment can prevent maternal and fetal complication and improve outcomes.
